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BACKGROUND: Coffee is the most widely consumed beverage in the world and has been known to have effects on cardiovascular system. Many 
researchers have examined the effects of coffee consumption 
on blood pressure (BP) and risk of cardiovascular disease 
(CVD), but their results were inconsistent and still remain a 
subject of controversy. Oxidative stress, inflammation, and 
endothelial dysfunction have been known as risk factors 
of hypertension and CVD. Those factors are also known 
to be affected by coffee consumption. The aim of this 
study was to examine the relationship between the effects 
of habitual coffee consumption on BP and to examine the 
role of oxidative stress (F2 isoprostane), inflammation 
(high sensitive C-reactive protein (hsCRP)) and endothelial 
dysfunction (asymmetric dimethylarginine (ADMA)).
METHODS: This was a cross-sectional study in which 
forty-seven healthy, non-smoking men aged 30-60 years 
with varying coffee-drinking habits were enrolled. BP and 
blood/urine analysis of biomarkers were measured in the 
morning before activity. Coffee consumption was assessed 
using a questionnaire. The differences among variables 
were analyzed using ANOVA and the correlations between 
variables were analyzed using Kendall’s Tau correlation 
analysis.
RESULTS: Habitual coffee consumption did not correlate 
with systolic / diastolic BP (r=-0.02; p=0.856 and r=0.15; 
p=0.230, respectively). Concentrations of ADMA and 
hsCRP were also not correlated with coffee consumption 
(r=0.03; p=0.764 and r=0.04; p=0.701, respectively). Coffee 
LATAR BELAKANG: Kopi adalah minuman yang banyak dikonsumsi di dunia dan diketahui memiliki pengaruh terhadap sistem kardiovaskular. Banyak 
penelitian telah dilakukan untuk melihat hubungan antara 
kebiasaan minum kopi dengan peningkatan tekanan darah 
(TD) dan risiko kejadian Penyakit Kardiovaskular (PKV), 
tetapi hasilnya tidak konsisten dan tetap menjadi perdebatan 
sampai saat ini. Stres oksidatif, inflamasi dan disfungsi 
endotel telah diketahui sebagai faktor risiko terjadinya 
hipertensi dan PKV. Faktor-faktor risiko tersebut diketahui 
dapat dipengaruhi oleh kebiasaan minum kopi. Tujuan 
penelitian ini adalah untuk mengkaji pengaruh kebiasaan 
minum terhadap TD, stres oksidatif (F2 isoprostan), 
inflamasi (high sensitive C-reactive protein (hsCRP)) dan 
disfungsi endotel (asimetrik dimetilarginin/ADMA). 
METODE: Penelitian ini menggunakan metode potong 
lintang dengan jumlah subyek 47 orang pria dewasa yang 
sehat, berusia 30-60 tahun dengan bermacam tingkatan 
kebiasaan minum kopi. Pengukuran TD dan pemeriksaan 
parameter kimia dilakukan pada pagi hari sebelum aktivitas. 
Kebiasaan minum kopi diperoleh melalui pengisian 
kuisioner. Analisis perbedaan antara variabel penelitian 
dilakukan menggunakan ANOVA dan analisis hubungan 
antara variabel penelitian menggunakan metode Kendall’s 
Tau.
HASIL: Kebiasaan minum kopi tidak berhubungan 
dengan TD sistolik dan diastolik (r=-0,02; p=0,856 dan 
r=0,15; p=0,230). Konsentrasi ADMA dan hsCRP juga 
tidak berhubungan dengan kebiasaan minum kopi (r=0,03; 
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consumption only showed significant correlation with F2 
isoprostane (r=0.34; p=0.004).
CONCLUSION: BP was not affected by coffee consumption 
although coffee consumption has a significant correlation 
with F2 isoprostane. These findings suggest that correlation 
between coffee consumption and BP might be explained by 
other factors that were not included in this study.
KEYWORDS: coffee, caffeine, cardiovascular disease, 
blood pressure, oxidative stress, inflammation, endothelial 
dysfunction
Indones Biomed J. 2013; 5(1): 51-8
Coffee is the most widely consumed beverage in the world 
and is the main source of caffeine. Coffee has been widely 
consumed for centuries for its psychostimulant effect. 
Coffee exposure may actually take place since before birth, 
as caffeine can cross the placenta barrier, and it continues 
throughout adulthood life.(1,2) Considering its extensive 
use and public health importance, it is necessary that a study 
on the effects of coffee consumption on blood pressure (BP) 
and cardiovascular disease (CVD) be carried out.
 Coffee contains several biologically active substances 
which have various effects, either harmful or beneficial on the 
cardiovascular system. Cafestol and kahweol, a diterpenoid 
alcohol compound present in unfiltered coffee brews have 
been known as hypercholesterolemic compounds. The 
chlorogenic acid, flavonoids, melanoidins and various lipid-
soluble compounds such as furans, pyrroles and maltol are 
well absorbed and have been shown to have antioxidant 
properties. In some populations coffee is the main source of 
antioxidant.(3-6)
 Caffeine (1,3,7-timethylxanthine) is the best 
characterized compound in coffee. More than 80% of the 
world’s population ingests caffeine daily that is mostly 
derived from coffee, tea and caffeinated soft drinks. 
Caffeine is rapidly absorbed from gastrointestinal tract into 
the blood stream. Approximately 90% of caffeine is cleared 
from stomach after 20 minutes. Peak plasma concentration 
is reached within 40-60 minutes. The structure of caffeine is 
similar to that of adenosine, therefore the main mechanism 
of action is antagonistic to adenosine. Caffeine occupies the 
adenosine receptor sites, especially A1 and A2a, thereby 
blocking the regulatory effect of adenosine. Thus the effect 
of caffeine is broadly stimulatory.(1,3,7,8)
 Reports of adverse cardiovascular effects of caffeine 
have suggested it an important issue underlying the 
association between coffee and CVD. Researchers have 
examined the effects of coffee/caffeine consumption on 
BP and risk of CVD. The results were inconsistent and still 
remain a subject of controversy. Cohort studies generally 
have not supported a significant association between coffee 
consumption and CVD. Case control studies tend to support 
a significant association between coffee consumption and 
risk of CVD.(1,3,9) A meta-analysis of 16 studies conducted 
by Noordzij et al.(10) showed an elevation of 2.04 mmHg 
for systolic BP (SBP) and of 0.73 mmHg for diastolic BP 
(DBP).
 Several mechanisms have been proposed to explain 
the association between coffee consumption and the risk 
of CVD. The potential mechanisms include the effect of 
caffeine on BP, elevated cholesterol and homocysteine 
level, oxidative stress, inflammation and endothelial 
dysfunction(3), which still are not very clear. The aim of 
this study was to examine the relationship between habitual 
coffee consumption on BP and to examine the mechanism 
underlying the relationship.
p=0,764 dan r=0,04; p=0,701). Kebiasaan minum kopi 
hanya menunjukan hubungan yang bermakna dengan F2 
isoprostan (r=0,34; p=0,004).
KESIMPULAN: TD tidak dipengaruhi oleh kebiasaan 
minum kopi meskipun kebiasaan minum kopi memiliki 
hubungan bermakna dengan F2 isoprostan. Hasil penelitian 
ini menunjukan bahwa hubungan antara kebiasaan minum 
kopi dengan peningkatan TD mungkin disebabkan oleh 
faktor lain yang tidak dianalisis dalam penelitian ini.
KATA KUNCI: kopi, kafein, penyakit kardiovaskular, 
tekanan darah, stres oksidatif, inflamasi, disfungsi endotel
Introduction
Methods
Study design
This was a cross-sectional study. Forty-seven healthy, non-
smoking men aged 30-60 years with varying coffee-drinking 
habits were recruited. All subjects gave informed consent to 
participate in the study. Ethical approval was obtained from 
Health Research Ethics Committee, Faculty of Medicine, 
University of Hasanuddin, Makassar. Data were collected 
from January to March 2008.
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Subjects
The study subjects were recruited from patients who 
came to Prodia Clinical Laboratory, Denpasar, for having 
general medical check-up, as well as Prodia’s employees. 
All subjects were apparently in good health conditions and 
willing to participate in the study. Subjects who had been 
consuming antioxidant supplement for the last 3 months, 
consumed anti-inflammatory drugs, had kidney dysfunction 
(glomerular filtration rate (GFR) < 60 mL/min), were 
diabetic (fasting glucose ≥ 126 mg/dL), had hypertension 
(SBP ≥ 140 mmHg, DBP ≥ 90 mmHg and/or treated with 
antihypertensive drugs) and acute inflammation (high 
sensitive C-reactive protein (hsCRP) > 10 mg/dL), were 
excluded from the study. Subjects with a waist circumference 
(WC) of more than 90 cm and were current smokers were 
also excluded from the study.
Demographic data and questionnaire
All tests were conducted in the morning, prior to any 
physical activity. After the consent process, all subjects 
were ask to fill in a questionnaire. The questionnaire was 
used to assess subject’s demographic data, past medical 
history, dietary intake and coffee-drinking habit. The coffee-
drinking habit was categorized into four groups: non-coffee, 
light/occasional coffee (≤1 cup/day), moderate coffee (2-3 
cups/day) and heavy coffee (>3 cups/day) drinkers.
BP measurement
BP was measured using calibrated sphygmomanometer. 
Subjects were seated for at least 5 minutes prior to 
measurement. The first Korotkoff sound represents SBP 
and the fifth Korotkoff sound represents DBP. Three 
measurements were taken at 5 minutes interval. The average 
of the second and third measurement was used.
Anthropometric measurement
Body weight (BW) was measured in kilograms to the nearest 
0.1 kg. Height was measured in centimeters to the nearest 
0.1 cm. WC was measured in centimeters to the nearest 0.1 
cm using a flexible non-elastic tape (Roche, Switzerland). 
WC was measured at the midway region between the lowest 
rib margin and the iliac crest, in standing position, abdomen 
relaxed, feet close together and weight equally divided over 
both legs.
Blood analysis
Fasting blood and first/second urine samples were collected 
in the morning after the subjects had completed the 
questionnaire and anthropometric measurement. Serum 
was used for analysis of fasting blood glucose, creatinine, 
hsCRP, and asymmetric dimethylarginine (ADMA). 
Plasma ethylenediaminetetraacetic acid (EDTA) was used 
for caffeine analysis. Glucose and creatinine levels were 
determined using reagent from Roche Diagnostic (Roche 
Diagnostic GmBH, Switzerland). hsCRP was determined 
using high-sensitivity chemiluminescent assay on 
Immulite Instrument (DPC, Los Angeles, CA). ADMA was 
determined using enzyme immunoassay for the quantitative 
determination of endogenous asymmetric dimethylarginine 
(DLD Diagnostic GmBH, Germany). Caffeine was 
determined by high-performance liquid chromatography 
(HPLC) method. Urine was used for F2 isoprostane 
analysis. F2 isoprostane was determined by enzyme linked 
immunosorbent assay (ELISA) method (Oxford Biomedical 
Research, Oxford, MI).
Data Analysis
Data analysis was done using SPSS 11.5 (SPSS Inc, 
Chicago, IL). Distributions of continuous variable were 
assessed for normality using Kolmogorov-Smirnov. The 
differences between variables were analyzed using ANOVA 
and the correlations between variables were analyzed using 
Kendall’s Tau correlation analysis. All tests were two-sided 
and considered significant at p < 0.05.
Results
Analysis of the data showed that from a total of 47 subjects, 
12 subjects (25.5%) were grouped as non coffee drinkers, 
20 subjects (42.6%) as light coffee drinkers and 15 
subjects (31.9%) as moderate coffee drinkers. No subjects 
were grouped as heavy coffee drinkers. Thirty-three 
subjects (94.3%) were reported of having habitual coffee 
consumption for more than 1 year and 2 subjects (5.7%) for 
1-12 months. Various demographic and clinical features of 
subjects are presented in Table1. Table 1 presents descriptive 
statistics for the different coffee drinkers groups (non, light 
and moderate coffee drinkers), while Table 2 present the 
difference between non coffee and coffee drinkers groups. 
Interestingly, data on the F2 Isoprostane concentrations 
showed marked differences between the groups (Table 2), 
but not significant (Table 2).
 Correlation results between variables using Kendall’s 
Tau correlation analysis are shown in Table 3. hsCRP values 
were log transformed because of their skewed distribution. 
Our results showed that coffee drinking habit was not 
correlated with SBP, DBP, log hsCRP and ADMA. Although 
not significantly correlated, SBP, DBP, and levels of hsCRP 
were higher in coffee drinkers group compared with non-
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coffee drinkers group (110.93+9.57 vs. 108.13+9.89; 
75.41+6.30 vs. 72.08+7.82 and 1.397+1.72 vs. 0.934+0.55, 
respectively) (Table 2). Coffee drinking habit was found 
significantly correlated with caffeine (r=0.23, p=0.049) and 
F2 isoprostane concentration (r=0.34, p=0.004).Discussion
The aim of this study was to examine the relationship 
between the effects of habitual coffee consumption on BP 
and to examine the role of oxidative stress (F2 isoprostane), 
inflammation (hsCRP) and endothelial dysfunction 
(ADMA). We found that BP was not correlated with coffee 
consumption. This findings support the previously reported 
cohort studies.
 A cohort study by Winkelmayer et al.(11) showed 
that there was no correlation between coffee consumption 
and hypertension in 155,549 United States of America 
women followed up over 12 years. Lopez-Garcia et al.(12) 
also showed that no correlation was found between coffee 
consumption and CVD in 44,005 men and 84,488 women 
followed up for 2-4 years. Klag et al.(13) reported that coffee 
consumption was associated with small increases in BP and 
played a small role in the development of hypertension.
 In contrast with the result of cohort studies, a 
randomized clinical trial with cross over conducted by 
Lovallo et al.(14) showed that caffeine acutely increased 
BP after 5 days of intervention. The effect was greater in 
people at high-risk of hypertension and was prolonged in 
those with confirmed hypertension. Hartley et al.(15) also 
found similar results. The caffeine was acutely increasing 
BP and exerting greater BP effects on those with a greater 
risk of hypertension.
 Caffeine is rapidly absorbed from the stomach. 
Approximately 99% of caffeine is cleared from the stomach 
within 45 minutes and peak plasma concentration is reached 
within 15-120 minutes. However the absorption is not 
complete when caffeine is taken as coffee.(16) In this study, 
BP measurements and blood biomarkers assessments were 
performed in the morning after overnight (10-12 hour) 
fasting. The average abstinence time for light coffee drinker 
s group was 20.70 ± 6.60 hours and 18.17 ± 4.30 hours for 
moderate coffee drinkers group. Caffeine concentrations 
were found to be 0.084 µg/mL, 0.197 µg/mL and 0.377 
µg/mL, for non, light and moderate coffee drinkers group, 
Table 1. Subjects Characteristics of Non, Light and Moderate Coffee Drinkers Groups.
Values are shown as mean + standard deviation. *significant at p<0.05, **significant at p<0.01.
Non Light Moderate 
n 12 (25.5%) 20 (42.6%) 15 (31.9%) -
Age (year) 39.750 ± 8.040 40.250 ± 7.960 41.730 ±  8.200 0.792
Height (cm) 167.402 ± 6.760 167.700 ± 5.510 165.130 ± 7.120 0.470
Weight (kg) 68.710 ± 5.780 66.230 ± 7.280 67.100 ± 8.040 0.642
WC (cm) 82.920 ± 4.930 83.630 ± 5.390 83.730 ± 5.060 0.908
SBP (mmHg) 108.130 ± 9.890 113.630 ± 6.760 107.330 ± 11.670 0.108
DBP (mm Hg) 72.080 ± 7.820 75.350 ± 5.600 75.500 ± 7.330 0.348
Abstinence - 20.700 ± 6.600 18.170 ± 4.300 0.231
Caffeine (µg/mL) 0.084 ± 0.090 0.197 ± 0.210 0.377 ± 0.470 0.049*
F2 isoprostane
(pg F2 / mg Creatinine)
84.770 ± 38.830 74.900 ± 23.480 119.810 ± 32.220 <0.001**
hsCRP (mg/L) 0.934 ± 0.550 1.564 ± 2.140 1.174 ± 0.930 0.507
ADMA (µmol/L) 0.678 ± 0.080 0.693 ± 0.130 0.696 ± 0.140 0.924
Variable
Coffee Drinkers Group
p
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respectively (Table 1). Those concentrations are far below 
the therapeutic dose of caffeine (8.0-20.0 µg/mL).(17) 
Interestingly, caffeine was also found in the sample of non-
coffee drinkers group, suggesting that these subjects might 
have been having caffeine-contained meals or drinks other 
than coffee, possibly tea or caffeinated soft-drinks.
 The correlation between coffee consumption and BP 
may greatly depend on the time lag between exposure/
consumption and BP measurements. The influence of 
coffee consumption (caffeine) on BP may vary from zero 
when plasma caffeine levels are depleted to several mmHg 
when plasma caffeine has been replenished. An overnight 
abstinence may lead to only modest increases in BP. An 
acute effect of caffeine may also explain the conflicting 
result of the many studies relating to coffee consumption 
and BP. Studies with shorter follow-up periods may report 
Table 2. Subjects Characteristics of Non Coffee and Coffee Drinkers Groups.
Values are shown as mean + standard deviation.
Coffee Drinkers Groups Caffeine F2 isoprostane Log hsCRP ADMA
r r r r r
Age - - -0.01 -0.01 0.24*
SBP -0.02 -0.25 -0.19 -0.15 -0.07
DPB 0.15 0.21 0.03 -0.12 -0.17
Caffeine 0.23* 1 0.13 0.01 -0.03
F2 isoprostan 0.34** 0.13 1 -0.03 -0.06
Log hsCRP 0.04 0.01 -0.03 1 0.19
ADMA 0.03 -0.03 -0.06 0.19 1
Variable
Table 3. Correlation Coefficients of Non Coffee vs. Coffee Drinkers Groups and Among All Variables.
*significant at p<0.05, **significant at p<0.01.
Non Coffee Drinkers Coffee Drinkers
n 12 (25.5%) 20 (42.6%) -
Age (year) 39.750 ± 8.040 40.890 ± 7.980 0.673
Height (cm) 167.420 ± 6.760 166.600 ± 6.280 0.705
Weight (kg) 68.710 ± 5.780 66.600 ± 7.510 0.381
WC (cm) 82.920 ± 4.930 83.670 ± 5.170 0.661
SBP (mm Hg) 108.130 ± 9.890 110.930 ± 9.570 0.39
DBP (mm Hg) 72.080 ± 7.820 75.410 ± 6.300 0.144
Caffeine (µ g/mL) 0.084 ± 0.090 0.274 ± 0.360 0.076
F2 isoprostane 
(pg F2 / mg Creatinine)
84.770 ± 38.830 94.140 ± 35.270 0.443
hsCRP (mg/L) 0.934 ± 0.550 1.397 ± 1.720 0.367
ADMA (µmol/L) 0.678 ± 0.080 0.694 ± 1.130 0.694
Variable
 Group
p
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positive effect compared to longer follow-up period.
(1,3,18,19) The studies conducted by Mesas et al.(20), 
Zampelas et al.(21), and Papamichael et al.(22) also showed 
that habitual (chronic) coffee consumption only have little 
effect on BP and biomarker, whereas the acute consumption 
have more significant effect on BP and biomarker.
 In this study, blood collection was performed after 
one night fasting. Overnight fasting caused the caffeine 
concentration to get back to normal. This might be the 
reason why coffee consumption showed no correlation 
with BP, hsCRP and ADMA concentrations. Although 
not significantly correlated, BP among coffee drinkers 
was higher than that among non coffee drinkers; 110.93 
vs. 108.13 mmHg for SBP and 75.41 vs. 72.08 mmHg 
for DBP, respectively (Table 2). BP reduction even in a 
modest amount has the potential to reduce morbidity and 
mortality in general population, or at least it can delay 
the onset of hypertension. It has been estimated that a 
decrease of 2 mmHg in SBP would result in lower mortality 
of approximately 7% for coronary heart disease (CHD) 
and 10% for stroke.(23) The Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure (JNC VII) estimated 
that a decrease in the SBP of 5 mmHg would result in 14% 
overall reduction in mortality due to stroke, a 9% due to 
CHD and a 7% due to all cause mortality.(24)
 Although there was no significant correlation, the 
hsCRP concentrations in coffee drinkers (1.397 mg/L, 95% 
CI: 0.806–1.987) were higher than in non-coffee drinkers 
(0.934 mg/L, 95% confidence interval (CI): 0.584–1.284) 
(Table 2). There is a consensus that hsCRP level <1 mg/L 
is correlated with low risk of CVD, while hsCRP level 1-3 
mg/L is correlated with moderate risk of CVD. This result 
suggests that coffee consumption might increase the risk of 
CVD.
 Habitual coffee consumption was significantly 
correlated with F2 isoprostane concentrations (r=0.34, 
p=0.004). The mean of F2 isoprostane concentration among 
non, light and moderate coffee drinkers groups are 84.77 ± 
28.83, 74.90 ± 23.48 and 119.81 ± 32.22, respectively. The 
relatively low correlation (r=0.34) between habitual coffee 
consumption and F2 isoprostane was related to its non-linier 
correlation.  We found a U-shaped correlation between 
coffee consumption and F2 isoprostane concentration. The 
lowest F2 isoprostane concentration was at light coffee 
drinkers group and increased in moderate coffee drinkers 
group as well as in non-coffee drinkers group. Other studies 
also found similar result on the correlation between coffee 
consumption and the risk of CVD. They found that moderate 
coffee drinkers group had the lowest incidence of coronary 
event compared to non and heavy coffee drinkers group.(12, 
19, 25-29)
 Coffee has unique biological and metabolic properties. 
Coffee is a complex mixture of harmful and beneficial 
compounds. The chlorogenic acid, flavonoids, melanoidins 
and various lipid-soluble compounds such as furans, pyrroles 
and maltol are some compounds that have beneficial effects 
(antioxidant). Epidemiological studies have found that in 
some populations coffee is the main source of antioxidant.
(6,25) The antioxidant compounds in coffee are absorbed 
rapidly after ingestion which may lead to the elevated level 
of antioxidant in circulation. On the other hand, caffeine 
increases angiotensin II production by inhibiting adenosine 
A1 receptor on the production of renin.(22) The balance 
between pro-oxidative and antioxidant compounds in coffee 
may be an important factor that determines its effects on 
blood pressure and biological markers, which needs to be 
elaborated further.(30)
 The conflicting result of the many studies relating 
to coffee consumption and BP may be due to inadequate 
adjustment of confounding variables. Coffee consumption 
has become part of modern life-style, together with smoking 
and alcohol consumption. More than 50% of women and 
30% of men who drink coffee at least 6 cups/day also 
smoke cigarette. Caffeine’s half-life is reduced by 30-50% 
in smoker compared to non smoker.(10,16) Smoking habit 
was excluded in this study. We also adjusted the other 
confounding factors, such as sex, age, alcohol consumption, 
WC, medical history (acute inflammation, hypertension, 
diabetes, renal failure), and dietary factors (antioxidant/
vitamin/energy drinks consumption).
 The method of coffee preparation (boiled, filtered), 
the type of coffee (black coffee, instant coffee), varieties of 
coffee (arabica, robusta) and the exact amounts of coffee 
ingested are also important confounding factors that may 
affect the outcome of the study. However, in this study we 
did not adjust those factors.
 More than 95% caffeine metabolism in the liver 
is mediated by cytochrome P450 (CYP) 1A2. The 
large variability of the enzyme is responsible for the 
interindividual variability in caffeine metabolism. The 
genetic modifier of exposure and the genetic of biological 
effect may play an important role in the correlation between 
coffee consumption and CVD.(31) This remains an issue to 
be further elaborated.
 It is also important to note that this research, being a 
cross sectional study, posses various limitations. Therefore, 
a further study needs to be carried out with a greater number 
of subjects, diverse coffee drinking habits categories (non, 
low, moderate, heavy coffee drinkers), and involving 
assessment of genetic polymorphism in CYP1A2 enzyme.
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Conclusion
Habitual coffee consumption does not correlate with BP 
although it has  partial correlation with F2 isoprostane. 
These findings suggest that correlation between coffee 
consumption and BP might be explained by other 
confounding factors.
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